Dyslipidemia in Children: Diagnosis and Management

Abstract

1. Ose L. An update of familial hypercholesterolemia. Ann Med 1999;31Suppl 1:13–8. 2. Lindgren V, Huskey KL, Russel DW, et al. Human genes involved in cholesterol metabolism. Chromosomal mapping of the loci for the low density receptor and 3hydroxy-3-m35hylglutary-coenzyme A reductase with cDNA probes. Proc Natl Acad Scie USA 1985;82:8567–71. 3. Kwiterovich PO. Identification and treatment of heterozygous familial Hypercholesterolemia in children and adolescents. Am J Cardiol 1993;72:30D–7D. 4. Kwiterovich PO. Biochemical, clinical, epidemiological, genetic, and pathological data in the pediatric age group relevant to the cholesterol hypothesis. Pediatrics 1992; 89:525–84. 5. Academy of Pediatrics: National Cholesterol Education Program: report of the expert panel on blood cholesterol levels in children and adolescents. Pediatrics 1992;89: 525–84. 6. Wiegman A, Rodenburg J, De Jongh S, et al. Family history and cardiovascular risk in Familial Hypercholesterolemia: data in more than 1000 children. Circulation 2003;107:1473–78. 7. Tonstad S Stratification of risk in children with familial Hypercholesterolemia with focus on psychological issues. Nutr Metabol Cardiovasc Dis 2001;11(Suppl 5): 64–7. 8. Tonstad S, Refsum H, Sivertsen M, et al. Relation of homocystein and lipid levels in children to premature cardiovascular death in male relatives. Ped Res 1996;40: 47–52. 9. Tonstad S, Joakimsen O, Stensland-Bugge E, et al. Risk factors related to carotid intima-media thickness and plaque in children with familial hypercholesterolemia and controls. Arterioscler Thromb Vasc Biol 1996;16: 984–91. 10. Tonstad S, Refsum H, Ose L, et al. The C677T mutation methylenetertrahydrofolate reductase gene predisposes to hyperhomocysteinemia in children with familial hypercholesterolemia treated with cholestyramine. J Pediatr 1998;132:365–8. 11. Umans-Eckenhausen MAW, Sijbrands EJG, Kastelein JJP, et al. Low Density Lipoprotein-receptor gene mutations and cardiovascular risk in a large genetic cascade screening population. Circulation 2002;106:3031–6. 12. Couture C, Brun LD, Szots F, et al. Association of specific LDL receptor gene mutations with differential plasma lipoprotein response to simvastatin in young French Canadians with heterozygous familial hypercholesterolemia. Arterioscler Thromb Vasc Biol 1998;18: 1007–12. 13. Fouchier SW, Defesche JC, Kastelein JJP. Global perspectives of familial hypercholesterolemia. Community Genet 2001;4:61–7. 14. Leren TP, Finborud TH, Manshaus TE, et al. Diagnosis of familial hypercholesterolemia in general practice using clinical diagnostic creiteria or genetic testing as part of cascade screening. Community Genet 2008;11:26–35. 15. Bhatnagar D, Morgan J, Siddize S et al. Outcome of case finding among relatives of patients with know heterozygous familial hypercholesterolemia. BMJ 2000; 321:1–5. 16. Tonstad S, Vollebaek LE, Ose L. Screening for familial hypercholesterolemia in relatives. Lancet 1995;346:1438. 17. Tell GS, Mittelmark MB, Vellar OD. Cholesterol, high density lipoprotein cholesterol and triglycerides during puberty: the Oslo Youth study. Am J Epidemiol 1985; 122:750–761. 18. Umans-Eckenhausen MAW, Oort FJ, Ferenchild KCMP. Parental attitude towards genetic testing for familial hypercholesterolemia in children. J Med Genet 2002; 39. 19. Campagna F, Martino F, Bifolco M, et al. Detection of familial hypercholesterolemia in a cohort of children with